N-[(1-methyl-1H-1,3-benzodiazol-2-yl)(phenyl)methyl]ethene-1-sulfonamide
Structure Info
- Chemspace ID
- CSSB06713687301 (In-Stock Building Blocks)
- IUPAC Name
- N-[(1-methyl-1H-1,3-benzodiazol-2-yl)(phenyl)methyl]ethene-1-sulfonamide
- Mol formula
- C17H17N3O2S
- Mol weight
- 327 Da
- Catalog Number(s)
- BBLS06713687301, EN300-54820414, bbls06713687301
- Copy structure to query editor
- SMILES
- INCHI
- INCHI key
- MOL
Properties
- LogP
- 2.66
- Heavy atoms count
- 23
- Rotatable bond count
- 4
- Number of rings
- 3
- Carbon bond saturation, Fsp3
- 0.11764705882353
- Polar surface area (Å)
- 64
- Hydrogen bond acceptors count
- 3
- Hydrogen bond donors count
- 1
![Chemical structure of N-[(1-methyl-1H-1,3-benzodiazol-2-yl)(phenyl)methyl]ethene-1-sulfonamide (C17H17N3O2S) - CSSB06713687301](/st/structure/200/d858c618234ed396ee0389a6fca807b8/C%253DCS%2528%253DO%2529%2528%253DO%2529NC%2528C1%253DCC%253DCC%253DC1%2529C1%253DNC2%253DC%2528C%253DCC%253DC2%2529N1C.png "C17H17N3O2S")
- Zoom the structure
- CSSB06713687301
Items Overall 8 items from 1 supplier
| Supplier | Lead time | Ships from | Purity | Pack | Price, $ | Qty |
|---|---|---|---|---|---|---|
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 50 mg | 455.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 100 mg | 477.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 250 mg | 498.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 500 mg | 519.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 1 g | 541.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 2.5 g | 1,063.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 5 g | 1,572.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 10 g | 2,331.00 |
For a custom pack size or bulk
please drop us a line:Enquire
please drop us a line:Enquire
Similarity Analogs
![Chemical structure of N-[1-(1-methyl-1H-1,3-benzodiazol-2-yl)ethyl]ethene-1-sulfonamide - CSSB21332052394](/st/structure/200/d66f794ce3aba6db277d67f5cd748d47/CC%2528NS%2528%253DO%2529%2528%253DO%2529C%253DC%2529C1%253DNC2%253DC%2528C%253DCC%253DC2%2529N1C.png)
![Chemical structure of N-[(1-methyl-1H-1,3-benzodiazol-2-yl)(phenyl)methyl]prop-2-enamide - CSSB02077547457](/st/structure/200/cb4f51d7aed86b4be49b01f437595ffd/C%253DCC%2528%253DO%2529NC%2528C1%253DCC%253DCC%253DC1%2529C1%253DNC2%253DCC%253DCC%253DC2N1C.png)
![Chemical structure of N-[(1-methyl-1H-pyrazol-3-yl)(phenyl)methyl]ethene-1-sulfonamide - CSSB21332101802](/st/structure/200/80a93a6dbfcaed31d5450cdf7b4d5b9b/CN1C%253DCC%2528%253DN1%2529C%2528NS%2528%253DO%2529%2528%253DO%2529C%253DC%2529C1%253DCC%253DCC%253DC1.png)
![Chemical structure of N-[(3-fluorophenyl)(1-methyl-1H-imidazol-2-yl)methyl]ethene-1-sulfonamide - CSSB21332166579](/st/structure/200/03242d3efc18e8297fc10df0fe484791/CN1C%253DCN%253DC1C%2528NS%2528%253DO%2529%2528%253DO%2529C%253DC%2529C1%253DCC%2528F%2529%253DCC%253DC1.png)
![Chemical structure of tert-butyl N-[(1-methyl-1H-1,3-benzodiazol-2-yl)(phenyl)methyl]carbamate - CSSB00025946271](/st/structure/200/e233aba433c27f50fff06cfb2c61ab03/CN1C%2528%253DNC2%253DCC%253DCC%253DC12%2529C%2528NC%2528%253DO%2529OC%2528C%2529%2528C%2529C%2529C1%253DCC%253DCC%253DC1.png)
![Chemical structure of N-[(1-methyl-1H-1,3-benzodiazol-2-yl)methyl]ethene-1-sulfonamide - CSSB06579076479](/st/structure/200/db95cf2fa5f9ecaaeee485079077ec69/C%253DCS%2528%253DO%2529%2528%253DO%2529NCC1%253DNC2%253DC%2528C%253DCC%253DC2%2529N1C.png)
